ORLANDO, Fla. – PerkinElmer Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced a new version of its industry-leading WinLab32™ for AA (Atomic Absorption) software at PITTCON® 2006, Booth 2669.  Designed to meet the rigorous needs of today’s analytical laboratories, the new WinLab32 for AA software is equipped with an integrated Quality Control (QC) Charting option to provide customers with a convenient and comprehensive solution to increase flexibility and productivity. 

PerkinElmer’s QC Charting feature allows laboratories to quickly and easily prepare quality control charts from results, as well as store customized templates for future use, without purchasing additional third-party software.  In addition, the feature provides laboratories with the ability to plot results from QC samples, standards, blanks or other samples, include limit ranges, means or expected values, and export results as ASCII data for use with other applications.

“For more than 40 years, PerkinElmer has been combining its technology expertise with an intimate understanding of customers’ needs to deliver innovative, cutting-edge Atomic Spectroscopy solutions,” said Jonathan Rennert, vice president and general manager, Analytical Sciences, for PerkinElmer’s Life and Analytical Sciences division.  “Our new WinLab32 for AA software will provide environmental, clinical and healthcare laboratories with a streamlined, efficient and integrated process for QC charting to help bring a new level of productivity to their laboratories.”

WinLab32 for AA software supports a wide range of sampling techniques, including: Flame, Furnace, FIAS-MHS, FIAS-Flame, FIASFurnace, FIMS and MHS (for manual MHS systems). This flexibility allows laboratories to select the best technique to analyze their samples. 

Additional key features of PerkinElmer’s WinLab32 for AA software include:

• Shares a common look and feel with ICP for easy cross-platform use;
• Extensive automated quality control options to ensure data quality;
• Wizards, multi-language Tool Tips and Tips of the Day make WinLab32 easy to learn and use;
• Data export allows selected data results to be transferred to a network computer;
• Powerful Examine Transient Peaks function accelerates method development; and
• An Enhanced Security (ES) version with check sums, audit trails and Windows® security for customers who need to meet regulatory requirements.

For more information on PerkinElmer’s WinLab32 for AA software, please visit: www.perkinelmer.com/winlab.

Factors Affecting Future Performance

This press release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities. Words such as “believes,” “intends,” “anticipates,” “plans,” “expects,” “projects,” “forecasts,” “will” and similar expressions, and references to guidance, are intended to identify forward-looking statements.  Such statements are based on management’s current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct.  A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements.  These factors include, without limitation: (1) economic and geopolitical forces that may limit any continued or expected economic or end market strengthening or recoveries; (2) risks related to our failure to introduce new products in a timely manner; (3) our ability to comply with financial covenants contained in our credit agreements and our debt instruments; (4) a delay in resolution of the Company’s tax audits and an adverse determination with respect to the Company’s tax audits by the Internal Revenue Service or other taxing authorities; (5) cyclical downturns continuing to affect several of the industries into which we sell our products; (6) our ability to adjust our operations to address unexpected changes; (7) our ability to execute acquisitions and license technologies and successfully integrate acquired businesses and licensed technologies into our existing business; (8) the loss of any of our licenses that may require us to stop selling products or lose competitive advantage; (9) competition; (10) regulatory compliance; (11) regulatory changes; (12) our failure to obtain and enforce intellectual property protection; (13) our defense of third party claims of patent infringement and our ability to realize the full value of our intangible assets; (14) other factors which we describe under the caption “Forward-Looking Information and Factors Affecting Future Performance” in our most recent annual report on Form 10-K and in our most recent quarterly report on Form 10-Q and in our other filings  with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

Other Information

Health Sciences end markets include genetic screening, environmental, service, biopharma, and medical imaging.  Photonics markets include sensors and specialty lighting.